The sales are too small to be informative — monitor for larger insider transactions or a cluster of C-suite buys for a real signal. The exercise-and-sell pattern is routine; no immediate trading action warranted.
Price Chart
Executive Summary
Two UroGen Pharma insiders — the Chief Medical Officer and General Counsel — sold a combined $102K in open-market shares on September 8, 2026, following non-cash option exercises the prior day. At a $2.1B market cap, the sales represent ~0.005% of market cap, well below the 0.1% threshold for materiality, and the exercise-and-sell pattern is consistent with routine tax-planning or diversification, not a bearish signal. The cluster is neutral — the dollar amount is trivial relative to company size, and the sales are liquidity-driven.
Key Financial Metrics
Key Facts
- CMO Mark Schoenberg sold 871 shares at $42.92 for $37K on 2026-09-08
- General Counsel Jason Drew Smith sold 1,519 shares at $42.54 for $65K on 2026-09-08
- Both insiders exercised stock options (non-cash) on 2026-09-07 before selling the next day
- Total open-market sales: $102K, or ~0.005% of $2.1B market cap
- No insider buying in the cluster — net direction is selling
Financial Impact
$102K in total insider sales, representing ~0.005% of market cap — trivial
Risk Factors
- Insiders could increase selling volume in future windows
- No insider buying to offset the sales — lack of bullish conviction signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-URGN-1788979067041 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $45.00 $43.04 | ▼ −4.36% | ▼ −4.02% | $41.40 (−8.00%) |
Aug 20, 2026 6w ago | 8-K | $46.80 $45.50 | ▼ −2.78% | ▼ −3.89% | $41.40 (−11.54%) |
Aug 5, 2026 8w ago | 8-K | $46.43 $49.00 | ▲ +5.54% | ▲ +5.18% | $41.40 (−10.83%) |
Jun 23, 2026 14w ago | 8-K | $35.42 $37.94 | ▲ +7.11% | ▲ +5.41% | $41.40 (+16.88%) |
Jun 2, 2026 17w ago | 8-K | $26.54 $28.18 | ▲ +6.18% | ▲ +9.14% | $41.40 (+55.99%) |
May 6, 2026 21w ago | Press Release | $26.25 $29.80 | ▲ +13.52% | ▲ +12.39% | $41.40 (+57.71%) |
Apr 29, 2026 22w ago | Press Release | $23.34 $23.83 | ▼ −2.10% | ▲ +1.01% | $41.40 (−77.38%) |
Mar 2, 2026 30w ago | Press Release | $19.02 $19.91 | ▲ +4.68% | ▲ +5.89% | $41.40 (+117.67%) |
Mar 2, 2026 30w ago | Press Release | $19.02 $19.91 | ▲ +4.68% | ▲ +5.89% | $41.40 (+117.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access